Cargando…
APOE Genotype-Function Relationship: Evidence of −491 A/T Promoter Polymorphism Modifying Transcription Control but Not Type 2 Diabetes Risk
BACKGROUND: The apolipoprotein E gene (APOE) coding polymorphism modifies the risks of Alzheimer's disease, type 2 diabetes, and coronary heart disease. Aside from the coding variants, single nucleotide polymorphism (SNP) of the APOE promoter has also been shown to modify the risk of Alzheimer&...
Autores principales: | Geng, Hua, Law, Peggy P. Y., Ng, Maggie C. Y., Li, Ting, Liang, Li-Yun, Ge, Tian-Fang, Wong, Kam-Bo, Liang, Chun, Ma, Ronald C., So, Wing-Yee, Chan, Juliana C. N., Ho, Yuan-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196492/ https://www.ncbi.nlm.nih.gov/pubmed/22028770 http://dx.doi.org/10.1371/journal.pone.0024669 |
Ejemplares similares
-
Apolipoprotein M Gene (APOM) Polymorphism Modifies Metabolic and Disease Traits in Type 2 Diabetes
por: Zhou, Jun-Wei, et al.
Publicado: (2011) -
Aldose Reductase Genotypes and Cardiorenal Complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients
por: So, Wing-Yee, et al.
Publicado: (2008) -
Interaction Effect of Genetic Polymorphisms in Glucokinase (GCK) and Glucokinase Regulatory Protein (GCKR) on Metabolic Traits in Healthy Chinese Adults and Adolescents
por: Tam, Claudia H.T., et al.
Publicado: (2009) -
An optimized method for PCR-based genotyping to detect human APOE polymorphisms
por: Najd-Hassan-Bonab, Leila, et al.
Publicado: (2023) -
SUN-491 An Uncommon Presentation of Primary Hiperparathyroidism
por: Bastos, Filipa, et al.
Publicado: (2019)